Tenecteplase Matches Alteplase in Safety and Effectiveness for Acute Ischemic Stroke, Study Finds Medha Baranwal23 March 2025 8:00 PM ISTUSA: A recent large-scale study evaluating real-world clinical data has found that tenecteplase is as effective and safe as alteplase for patients...
FDA Approves Tenecteplase as First Stroke Drug in Nearly 30 Years Dr. Kamal Kant Kohli5 March 2025 7:00 AM ISTThe US Food and Drug Administration has approved Tenecteplase as first FDA-approved stroke medication in nearly three decades. It offers a significant...
In ischaemic stroke, Tenecteplase tied to better recovery and reduced disability than alteplase: Study Dr. Kamal Kant Kohli18 Oct 2024 7:00 AM ISTFor people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent...
Tenecteplase Viable Alternative to Alteplase for Acute Ischemic Stroke in Chinese Patients, reports research Dr.Niharika Harsha B23 Sept 2024 9:15 PM ISTA recent innovative multicenter study conducted in China has found that tenecteplase, a bioengineered variant of alteplase, is noninferior with...
Study supports thrombolysis with tenecteplase in patients with ischemic stroke Medha Baranwal4 Jun 2023 8:00 PM ISTUSA: Stroke thrombolysis with tenecteplase is associated with lower odds of symptomatic intracranial haemorrhage (sICH) than treatment with alteplase,...
Thrombolytic therapy with tenecteplase increased early reperfusion in mobile stroke units: Lancet Jacinthlyn Sylvia1 July 2022 11:15 AM ISTAustralia: A new study conducted by Andrew Bivard and his team shows that tenecteplase treatment on the mobile stroke units (MSUs) resulted in a...
Tenecteplase yields worse safety and functional outcomes compared to alteplase in ischaemic stroke: Lancet Dr. Shravani Dali14 May 2022 9:00 AM ISTIn a dose of 0·4 mg/kg tenecteplase yielded worse safety and functional outcomes compared with alteplase in a prematurely terminated study. The study...
Tenecteplase extends Window for Additional Stroke Treatment up to 24 Hrs MD Bureau18 Feb 2022 9:45 AM ISTTenecteplase is a type of tPA (tissue-type plasminogen activator) of increasing interest for the thrombolytic treatment of acute ischemic stroke due...
IV alteplase use fails to improve functional outcomes in patients with ICH and IVH: JAMA Medha Baranwal20 Dec 2021 9:00 AM ISTUSA: Intraventricular alteplase use is associated with a small reduction in the parenchymal intracerebral hemorrhage (ICH) volume in patients with...
tPA benefit consistent upto 9 hours in stroke patients: JAMA Medha Baranwal7 Nov 2020 11:23 AM ISTAustralia: Stroke patients selected using perfusion mismatch had consistent treatment effect of alteplase (or tPA) throughout the 4.5- to 9-hours and...
Alteplase use safe in stroke patients above 80 years also: Study Dr.Niharika Harsha B8 Sept 2020 6:51 PM ISTA recent study has found that Alteplase has a positive benefit-risk profile among elderly patients. The study was published in the journal, "Stroke"...
New Delhi : Neurologist challenges Stroke Drug Approval in high court savita thakur thakur26 Aug 2016 9:54 AM ISTNew Delhi: In what would be probably a first, a Delhi based- neurologist has dragged the Union Government and DCGI (Drug Controller General of India)...
